Regulated programmed cell death in sepsis associated acute lung injury: From pathogenesis to therapy
International Immunopharmacology · 2025
DOI: 10.1016/j.intimp.2025.114111 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Immunopharmacology, 2025. Verfasst von Rui-Ming Deng und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Ganzhou People's Hospital, 16 Meiguan Avenue, Ganzhou, Jiangxi Province 341000, PR China. Electronic address: 155701159…. Hauptthemen laut MEDLINE: Sepsis, Acute Lung Injury, Regulated Cell Death. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 235 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Themen: Sepsis
Abstract (Originalsprache)
Sepsis associated acute lung injury (SALI) is a common complication in patients with severe sepsis and a disease with high morbidity and mortality in ICU patients. The main mechanism of SALI is pulmonary hypoperfusion due to hypotension and shock caused by sepsis, which leads to ischemic necrosis of alveolar endothelial cells and eventually lung failure. At present, SALI therapy mainly includes antibiotic therapy, fluid resuscitation, transfusion products and vasoactive drugs, but these strategies are not satisfactory. Therefore, focusing on the role of different cell death patterns in SALI may help in the search for effective treatments. Understanding the molecular mechanisms of SALI and identifying pathways that inhibit lung cell death are critical to developing effective drug therapies to prevent the progression of SALI. Cell death is controlled by programmed cell death (PCD) pathways, including apoptosis, necroptosis, ferroptosis, pyroptosis and autophagy. There is growing evidence that PCD plays an important role in the pathogenesis of SALI, and inhibitors of various types of PCD represent a promising therapeutic strategy. Therefore, understanding the role and mechanism of PCD in SALI is conducive to our understanding of its pathological mechanism, and is of great significance for the treatment of SALI. In this article, we discuss recent advances in the role of PCD in SALI, show how different signaling pathways (such as NF-κB, PI3K/Akt, mTOR, and Nrf2) regulate PCD to regulate SALI development, and discuss the associations between various types of PCD. The aim is to explore the molecular mechanism behind SALI and to find new targets for SALI therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Anesthesiology, Ganzhou People's Hospital, 16 Meiguan Avenue, Ganzhou, Jiangxi Province 341000, PR China. Electronic address: 15570115910@163.com.
- Department of Anesthesiology, Ganzhou People's Hospital, 16 Meiguan Avenue, Ganzhou, Jiangxi Province 341000, PR China.
- Department of Anaesthesia, Seventh People's Hospital of Shanghai University of Traditional Chinese Medicine, Shanghai, 200137, PR China.
- Department of Thyroid and Breast Surgery, Ganzhou People's Hospital, 16 Meiguan Avenue, Ganzhou, Jiangxi Province 341000, PR China. Electronic address: 15107970562@163.com.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Deng, R. M., Huang, G., Wang, T., & Zhou, J. (2025). Regulated programmed cell death in sepsis associated acute lung injury: From pathogenesis to therapy. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2025.114111
Vancouver
Deng RM, Huang G, Wang T, Zhou J. Regulated programmed cell death in sepsis associated acute lung injury: From pathogenesis to therapy. International Immunopharmacology. 2025. doi:10.1016/j.intimp.2025.114111
BibTeX
@article{Deng2025,
author = {Deng, Rui-Ming and Huang, Guiming and Wang, Tingting and Zhou, Juan},
title = {Regulated programmed cell death in sepsis associated acute lung injury: From pathogenesis to therapy},
journal = {International Immunopharmacology},
year = {2025},
doi = {10.1016/j.intimp.2025.114111}
}
EUVIMED